during the quickly evolving industry of oncology investigation, precise and economical mutation screening is essential for developing targeted therapies. The KRAS solutions System performs a pivotal function in this landscape by featuring thorough remedies for KRAS mutation profiling and analysis. KRAS mutations, present in approximately ninety fiv